GovChime
Notice ID: e4da067c5c9f4e7e84528b45f2b8f924Presolicitation

Nucleic Acid Active Reagents/Kits for Panther and Fusion Instruments

Archived. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−10:00
Posted
February 8, 2022
Notice type
Presolicitation
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of WarDepartment of the Army

Notice details

Office
W40M MRCO PACIFIC
Place of performance
Tripler Army Medical Center, HI, 96859
Last updated
Dec 4, 2025

Identifiers

Solicitation number
W81K0222Q0026
Notice ID
e4da067c5c9f4e7e84528b45f2b8f924

Description

The Regional Health Contracting Office - Pacific, in support of MEDCOM, intends to make a sole source award to Gen-Probe, Inc. for a firm fixed-price contract for nucleic acid active reagents and assay kits for Panther Instruments at Tripler Army Medical Center. The NAICS code of this procurement is 325413. This requirement is for a period of performance from on or about 01 March 2022 through 30 September 2026 (base and four (4) one-year option periods). The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes; however, all responsible sources may submit a capability statement or quotation which shall be considered by the agency. All questions and responses concerning this notice shall be emailed to susan.m.fujita.civ@mail.mil. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response. AMENDMENT 0001: The purpose of this amendment is to revise CLIN descriptions, increase the option period CLIN quantities, add CLINs x010 and x011 and revise Attachment 1. The due date for submission of quotations was extended to February 8, 2022 at 12:00 pm (HST).

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:W81K0222Q0026
  1. Market Research
  2. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Market ResearchDec 3, 2021

    Nucleic Acid Active Reagents/Kits for Panther Instruments

    Notice 9a2017f8c3e149c283dcb3665477b171 on SAM.gov

  2. 2×
    Pre-SolicitationCurrentJan 13, 2022

    Nucleic Acid Active Reagents/Kits for Panther and Fusion Instruments

    Notice e4da067c5c9f4e7e84528b45f2b8f924 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This requirement for reagents, quality control, maintenance, consumables, and two (2) automated urine laboratory analyzers for use at United States Naval Health Clinic Hawaii (NHCH) Makalapa and Branch Health Clinic Kaneohe Bay was awarded as a firm-fixed-price, sole source, supply contract to Beckman Coulter, Inc. pursuant to FAR Subpart 13.5 and in accordance with 41 U.S.C. 1901 Simplified Acquisition Procedures after receiving no additional information from interested parties in response to Notice of Intent to Sole Source HT941023N0020.
-AwardedOpen
Phadia 250 Reagent and Consumables
-AwardedOpen
Combined synopsis/solicitation for Immunoassay Reagents, Supplies and Consumables to be used for patient testing on an existing Architect i1000 analyzer located at the Pathology and Laboratory Medicine Services in Southern Arizona VA Medical Center (VA Tucson).
-Combined Synopsis11/13/2026
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels.
-Market Research11/27/2026
-AwardedOpen

Additional Details

Solicitation Number

W81K0222Q0026

Archive Date

Not specified

Office Address

FORT SHAFTER, HI, 96858-5098